Neela Patel's Location
Belmont, California, United States, United States
Neela Patel's Contact Details
Neela Patel work email
- Valid
- Valid
- Valid
- Valid
- Valid
- Valid
Neela Patel personal email
n/a
Neela Patel phone numbers
About Neela Patel
•Breadth of business development transactions including collaborations, licensing, and M&A •Expert at evaluating and translating science into potential products•Deep knowledge and track record of success in drug discovery•Strategic planning expertise at corporate and pipeline level •Ability to build consensus with stakeholders and cultivate relationships
Neela Patel's Current Company Details
Neela Patel Work Experience Details
-
CboBonum TherapeuticsBelmont, Ca, Us
-
Board MemberInfinimmune May 2024 - PresentAlameda, California, Us -
CboBonum Therapeutics Sep 2022 - PresentSeattle, Wa, Us
-
Chief Business Development OfficerGood Therapeutics, Inc. Jun 2021 - Sep 2022Seattle, Washington, UsLed two major transactions • Spin-out from Good Therapeutics to Bonum Therapeutics of employees, platform, and all programs except PD1-IL2• Acquisition of Good Therapeutics (PD1-IL2 program) by Roche for $250 million upfront plus milestonesProvided strategic leadership for• Corporate communications, including media presence and website• Project and alliance management -
Executive Director Of Corporate DevelopmentSeattle Genetics May 2016 - May 2021Bothell, Washington, UsDeveloped and executed in-licensing strategy to augment and diversify pre-clinical and clinical portfolio with assets & technologies, and clinical combination trials• Sourced and executed deals that will account for 40% of new INDs in 2021-2022• Evaluate ~350 preclinical opportunities and ~100 clinical assets annually; maintain flow of 15-20 MTAs to enable sustainable portfolio; lead term sheet and contract negotiations.Leadership• Selected for Seattle Genetics’ Leadership Academy (16 participants out of 1200 employees)• Promoted culture open to external opportunities by collaborating with research and clinical leadership to evaluate and address gaps in pipeline flow• Brought company into new technical areas through licensing and collaborations -
Director, Search And Evaluation (Licensing)Abbvie Sep 2013 - Apr 2016• Sourced and evaluated 300-400 opportunities per year for licensing, investment, or acquisition with confidential review of 25-50 annually; opportunities included technology platforms, and assets from discovery through mid-clinical stage• Oversaw technical teams from initial evaluation through due diligence on selected opportunities; crafted appropriate business structure based on science; presented diligence findings to R&D leadership team• Catalyzed and managed annual oncology strategic planning process for five years, resulting in identification of prioritized focus areas and appropriate internal/external tactics• Managed biweekly licensing review team with therapeutic area leaders from research, development, legal, and transaction groups• 20+ executed deals over seven years, including multi-target licensing agreements with competitive upfront/milestones/sales milestones/royalties, drug discovery and development consortia, biotech collaborations to access key technologies or expertise, and academic collaborations
-
Director, Global External ResearchAbbott Laboratories Jul 2009 - Aug 2013Abbott Park, Illinois, UsAugmented Abbvie discovery pipeline with external target/drugs and technologies• Regional scout for western US: identified academic and biotech collaborative opportunities in oncology, neuroscience, immunology, renal, biologics and drug discovery technologies• Therapy area liaison for oncology. Assessed all incoming opportunities worldwide for technical robustness and strategic fit (>300/yr). Conducted proactive outreach globally to institutes, biotechs, consortia. Led technical diligence, including generation of collaboration models and workplans• Enabled focus areas: epigenetics with SGC participation and Epitherapeutics multi-target deal; antibody-drug conjugates by sourcing and executing agreements with linker-toxin and conjugation technologies; translational medicine with agreements to access databases, animal models, and IMI consortia; other early stage areas with academic collaborations• Abbott non-pharma divisions: contributed leads for diagnostics and medical device divisions, generated evaluations of oncology and ophthalmology leads for corporate venture -
Director, Preclinical And Translational MedicinePoniard Pharmaceuticals May 2006 - May 2009UsDeveloped strategy for pipeline with head of chemistry: number and type of projects, milestones, resources required, forecasting and management of research budget (~$6M total annual budget, $3M for studies conducted at CROs). Led project licensed to Verastem in 2011 for clinical development.• Oversaw establishment of new molecular and cell biology labs• Assembled network of CROs to perform PK/ADME and efficacy experiments• Conducted pre-clinical diligence on licensing opportunities: 200+ oncology opportunities evaluated, including competitive research, relative ranking of assets, and recommendations for terms sheets -
Assoc Director, Product Portfolio ManagementGenentech Dec 2003 - Apr 2006South San Francisco, California, UsEstablished and directed pre-clinical project management for internal and in-licensed projects (small molecule and biologics) through IND filing • Staffed, developed, and led project management group for Genentech’s late pre-clinical portfolioo Built and managed department of 9 pre-clinical project managers. Recruited and integrated 8 new staff members in 18 monthso Coached project managers to facilitate decision making and conflict resolution at project team and/or management levelo In two years, 5 INDs filed and achieved steady state portfolio of 15 projects• Prepared and delivered overall pre-clinical portfolio views to senior management, identified common themes from issues and instituted system wide solutions• Developed and implemented basic portfolio tracking for pre-clinical programs, rolling forecast for potential new projects from research, and capacity planning for 12-18 month horizon• Ensured identification of risks and mitigation plans for each project -
Associate Director, Discovery BiologySugen/Pharmacia Oct 2000 - Sep 2003New York, New York, Us• Therapy Area Leadership, Ophthalmologyo Ophthalmology Therapy Area Core Team Member (5 member team) o Developed strategy for therapy area, secured management approval for new TA. Team subsequently responsible for ophthalmology research portfolio• Ophthalmology Discovery Licensing Team Member: identified and evaluated in-licensing opportunities from scientific and strategic perspective• Project Team Leader: VEGFR inhibitors for retinal disease• Management: supervised cell biology group for small molecule discovery. Functional responsibilities included cell-based phenotypic and target modulation assays, and mechanism of action studies. Project-based responsibilities included mentoring oncology team leaders to ensure execution and delivery of milestones. -
Research ScientistRoche Bioscience, Palo Alto, Ca 1996 - 2000Project Team LeaderNew target identification for osteoporosis• Led multi-site team (Palo Alto, Antwerp, Basel) to identify human gene involved in bone formation by positional cloningSmall molecule antagonists of a G protein-coupled receptor for osteoporosis• Supervised team: HTS through in vivo proof of concept for target GPCRo Developed structure-activity relationship of lead compound with chemisto Designed experiments and performed data analysis to assess in vivo efficacy of compounds
-
Postdoctoral FellowDnax Research Institute 1993 - 1996Us
Neela Patel Skills
Biotechnology
Drug Development
Drug Discovery
Clinical Development
Oncology
Immunology
Life Sciences
Molecular Biology
Biopharmaceuticals
Translational Medicine
Lifesciences
Biochemistry
Assay Development
Cancer
Pharmaceutical Industry
Biomarkers
Cell Culture
Biomarker Discovery
Technology Transfer
Cell Biology
Pharmacology
Medicinal Chemistry
Biologics
Ind
Clinical Research
Personalized Medicine
Neela Patel Education Details
-
UclaMolecular Biology -
Stanford UniversityBiology/Humanities
Frequently Asked Questions about Neela Patel
What company does Neela Patel work for?
Neela Patel works for Bonum Therapeutics
What is Neela Patel's role at the current company?
Neela Patel's current role is CBO.
What is Neela Patel's email address?
Neela Patel's email address is pa****@****ics.com
What is Neela Patel's direct phone number?
Neela Patel's direct phone number is +122447*****
What schools did Neela Patel attend?
Neela Patel attended Ucla, Stanford University.
What skills is Neela Patel known for?
Neela Patel has skills like Biotechnology, Drug Development, Drug Discovery, Clinical Development, Oncology, Immunology, Life Sciences, Molecular Biology, Biopharmaceuticals, Translational Medicine, Lifesciences, Biochemistry.
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial